Turner Paul A, Gurumurthy Bhuvaneswari, Bailey Jennifer L, Elks Carrie M, Janorkar Amol V
Department of Biomedical Materials Science, School of Dentistry, University of Mississippi Medical Center, 2500 N State Street, Jackson, MS.
Matrix Biology Laboratory, Pennington Biomedical Research Center, 6400 Perkins Road, Baton Rouge, LA.
Process Biochem. 2017 Aug;59:312-320. doi: 10.1016/j.procbio.2017.02.003. Epub 2017 Feb 6.
Understanding the process of adipogenesis is critical if suitable therapeutics for obesity and related metabolic diseases are to be found. The current study presents proof of feasibility of creating a 3-D spheroid model using human adipose-derived stem cells (hASCs) and their subsequent adipogenic differentiation. hASC spheroids were formed atop an elastin-like polypeptide-polyethyleneimine (ELP-PEI) surface and differentiated using an adipogenic cocktail. Spheroids were matured in the presence of dietary fatty acids (linoleic or oleic acid) and evaluated based on functional markers including intracellular protein, CD36 expression, triglyceride accumulation, and PPAR-γ gene expression. Spheroid size was found to increase as the hASCs matured in the adipocyte maintenance medium, though the fatty acid treatment generally resulted in smaller spheroids compared to control. A stable protein content over the 10-day maturation period indicated contact-inhibited proliferation as well as minimal loss of spheroids during culture. Spheroids treated with fatty acids showed greater amounts of intracellular triglyceride content and greater expression of the key adipogenic gene, PPAR-γ. We also demonstrated that 3-D spheroids outperformed 2-D monolayer cultures in adipogenesis. We then compared the adipogenesis of hASC spheroids to that in 3T3-L1 spheroids and found that the triglyceride accumulation was less profound in hASC spheroids than that in 3T3-L1 adipocytes, correlated with smaller average spheroids, suggesting a relatively slower differentiation process. Taken together, we have shown the feasibility of adipogenic differentiation of patient-derived hASC spheroids, which with further development, may help elucidate key features in the adipogenesis process.
如果要找到治疗肥胖症及相关代谢疾病的合适疗法,了解脂肪生成过程至关重要。当前研究证明了使用人脂肪来源干细胞(hASC)创建三维球体模型及其随后进行脂肪生成分化的可行性。hASC球体在弹性蛋白样多肽-聚乙烯亚胺(ELP-PEI)表面形成,并使用脂肪生成混合液进行分化。球体在膳食脂肪酸(亚油酸或油酸)存在的情况下成熟,并根据包括细胞内蛋白质、CD36表达、甘油三酯积累和PPAR-γ基因表达等功能标志物进行评估。发现随着hASC在脂肪细胞维持培养基中成熟,球体尺寸增大,不过与对照相比,脂肪酸处理通常会导致球体较小。在10天的成熟期间蛋白质含量稳定,表明接触抑制增殖以及培养过程中球体损失最小。用脂肪酸处理的球体显示出细胞内甘油三酯含量更高,关键脂肪生成基因PPAR-γ的表达也更高。我们还证明,三维球体在脂肪生成方面优于二维单层培养。然后我们将hASC球体的脂肪生成与3T3-L1球体的脂肪生成进行比较,发现hASC球体中的甘油三酯积累不如3T3-L1脂肪细胞中那么显著,这与平均球体较小有关,表明分化过程相对较慢。综上所述,我们已经证明了患者来源的hASC球体脂肪生成分化的可行性,随着进一步发展,这可能有助于阐明脂肪生成过程中的关键特征。